Coagulase-Negative Staphylococci: Diversity, Adaptations, and Roles

Coagulase-negative staphylococci, commonly called CoNS, are a sprawling group of bacteria that live on virtually every person’s skin yet rank among the most frequent causes of hospital-acquired bloodstream infections. The group includes at least 55 genetically distinct species, and their behavior ranges from quietly protective to genuinely dangerous depending on the species, the strain, and the vulnerability of the host.¹ That range makes them one of the more underestimated groups in microbiology, and understanding their diversity reveals how the line between harmless resident and opportunistic pathogen can be remarkably thin.

What Makes Them “Coagulase-Negative”

The name is a contrast. Staphylococcus aureus, the most notorious member of the Staphylococcus genus, produces an enzyme called coagulase that clots blood plasma and helps it evade the immune system. CoNS lack that enzyme, which for decades made microbiologists treat them as minor players. They were often dismissed as contaminants when they turned up in blood cultures. That perception has changed sharply. CoNS are now recognized as one of the leading nosocomial pathogen groups, with S. epidermidis and S. haemolyticus being the most clinically significant species.²

How Many Species Exist and How They Differ

An analysis of nearly 1,900 publicly available CoNS genomes identified 55 species based on differences in hundreds of core genes and their accessory gene content.¹ Newer molecular tools using a set of five target genes can now reliably distinguish even closely related species within the genus, an improvement over older phenotypic tests that frequently misidentified CoNS.³

Within individual species, genetic diversity varies a lot. A study of four CoNS species commonly found in dairy cow udder infections showed that S. haemolyticus isolates were the most genetically heterogeneous, while S. epidermidis and S. chromogenes were more clonal, suggesting those species have particular strains that are well adapted to specific niches.⁴ Genomic analyses of food-derived CoNS strains confirmed that the group has an “open” pan-genome: every time researchers sequence a new strain, they find genes not seen before. The shared core across five analyzed species plateaus around 1,450 genes, but the total gene pool exceeds 4,500 and keeps growing.⁵

Life on Human Skin

S. epidermidis is the poster species for CoNS as commensals. It colonizes the skin of essentially every person and is far from a passive hitchhiker. It actively primes the skin’s immune defenses, helps maintain the skin barrier, and performs colonization resistance, meaning it occupies ecological space that would otherwise be available to more dangerous microbes.⁶ This dual lifestyle is central to the CoNS story: the same organism that protects your skin under normal conditions can turn pathogenic the moment it gets past the skin barrier and reaches a vulnerable internal site.

Another species, S. lugdunensis, takes colonization resistance a step further. It produces a peptide antibiotic called lugdunin that directly kills S. aureus on epithelial surfaces. Beyond its direct bactericidal effect, lugdunin also appears to amplify the host’s own innate immune responses in the skin, creating a two-pronged defense.⁷ The fact that a CoNS species manufactures its own antibiotic against a major human pathogen is one of the more striking examples of microbial interference on the body.

Biofilm Formation and Why It Matters

The single adaptation that most defines CoNS as hospital pathogens is biofilm formation. When S. epidermidis or a related species lands on an implanted medical device like a catheter, prosthetic joint, or heart valve, it can build a structured community of cells embedded in a self-produced matrix. This process follows a four-step sequence: the bacteria first adhere to the surface, then accumulate into multilayered clusters, mature into a three-dimensional architecture with channels, and eventually disperse cells that can colonize new sites.⁸

What makes biofilm so clinically frustrating is that bacteria inside it are sheltered from both antibiotics and the immune system. Drug concentrations that would easily kill free-floating cells often fail to penetrate the biofilm matrix. This is a major reason why CoNS-related device infections frequently require removal of the device itself rather than antibiotic treatment alone.⁹ The accumulation step during biofilm assembly can be driven by polysaccharides or by surface proteins, and different strains use different strategies, which complicates any universal approach to prevention.⁸

Hospital Infections and Vulnerable Populations

CoNS are among the top causes of catheter-related bloodstream infections, and they account for a substantial share of all foreign body-related infections in hospitals.² The patients most at risk tend to be those with indwelling devices, compromised immune systems, or immature immunity. Preterm newborns in intensive care are a particular concern because their skin barriers are fragile, they often need long-term central catheters, and their immune defenses are not yet fully functional.

What separates CoNS from S. aureus in terms of pathogenicity is largely the host’s condition. CoNS have fewer virulence tools than S. aureus, and the resulting disease profile is different: infections tend to be slower, more indolent, and harder to distinguish from contamination. Host susceptibility is therefore a much bigger factor in whether a CoNS encounter leads to infection.²

Species That Break the Mold

Not all CoNS behave like timid opportunists. Two species stand out for acting more aggressively than the group’s general reputation would suggest.

S. lugdunensis, the same species that produces the antibiotic lugdunin on skin, can cause acute and highly destructive native valve endocarditis when it reaches the heart. Unlike the slow-burning infections typical of other CoNS, S. lugdunensis endocarditis often involves rapid valve destruction, abscess formation, and heart failure. Surgical valve replacement is frequently necessary, and mortality is high.¹⁰ A clinical analysis of ten cases found that all patients with left-sided S. lugdunensis endocarditis had serious complications, with surgery required in the majority and an overall mortality rate of 80% in that subgroup.¹¹ This makes S. lugdunensis endocarditis more closely resemble the virulent pattern seen with S. aureus than the typical CoNS picture.¹²

S. saprophyticus takes a completely different route. Rather than targeting devices or heart valves, it is an established cause of urinary tract infections, particularly in sexually active young women. Its ability to adhere to urinary tract epithelial cells and survive immune defenses makes it a true standalone pathogen rather than just an opportunist waiting for a catheter.¹³

Quorum Sensing and Virulence Control

Bacteria coordinate group behavior through chemical signaling systems, and in staphylococci the key system is called Agr. S. epidermidis has three distinct Agr types, each using a different signaling peptide. Two of those peptides are twelve amino acids long, making them the largest of any known staphylococcal signaling molecules. The different Agr types can cross-inhibit each other: types I and II block each other, as do types I and III, but types II and III do not interfere. This cross-talk determines which strains can coexist and which outcompete each other during colonization.¹⁴

In S. haemolyticus, the Agr system plays a more directly dangerous role. Research using experimental sepsis models showed that the Agr quorum-sensing system strongly influences mortality by tightly controlling the production of cytolytic toxins called phenol-soluble modulins, or PSMs. Because Agr control in CoNS is so focused on these toxins, targeting Agr or PSMs could be a promising strategy for anti-virulence drugs against CoNS sepsis. Interestingly, this approach is considered less promising against S. aureus bloodstream infections, where the Agr system regulates a broader and more redundant set of virulence factors.¹⁵

Antibiotic Resistance and Gene Swapping

CoNS species are a significant reservoir of transferable antibiotic resistance genes, including nine types of the mobile genetic element SCCmec, which carries the methicillin resistance gene mecA.¹ Because CoNS live alongside S. aureus on human skin and mucous membranes, they can pass resistance genes to their more virulent neighbor. The intestinal tract is another suspected site for this gene exchange, as fecal CoNS isolates have been found carrying a genetic background compatible with interspecies transfer to S. aureus.¹⁶

Genomic comparisons of CoNS from different geographic regions have revealed that the resistance genes a strain carries often reflect local conditions. Isolates collected in Nigeria, for instance, carried cadmium resistance genes not seen in South African isolates, while South African strains harbored a tetracycline resistance gene absent in the Nigerian collection. These patterns correlate with anthropogenic activities in the areas where the bacteria were collected, such as industrial waste and agricultural antibiotic use.¹⁷

CoNS in Water and the Environment

CoNS are not confined to skin and hospitals. Studies have recovered antibiotic-resistant CoNS from wastewater treatment plants, drinking water treatment plants, and even from finished drinking water that meets all regulatory quality standards. Resistance to beta-lactams, tetracycline, clindamycin, and erythromycin was observed across all water types tested.¹⁸ In urban waterways near pharmaceutical manufacturing areas in Delhi, India, researchers found methicillin-resistant CoNS belonging to eight different species, with roughly 61% of those isolates showing multidrug resistance. Multiple resistance genes were detected, including mecA and blaZ.¹⁹

These environmental findings are part of a broader concern about the role CoNS play in the spread of antimicrobial resistance outside clinical settings. Their open pan-genome, ability to acquire mobile genetic elements readily, and presence in diverse environments make them a connecting thread between hospital, community, agricultural, and environmental resistance pools.

Bovine Mastitis and Dairy Farming

In veterinary medicine, CoNS have become the most commonly isolated group of bacteria from bovine mastitis cases in many countries. The infection tends to be subclinical rather than overtly dramatic: cows do not always show visible symptoms, but the infection raises milk somatic cell counts and reduces milk quality and production. CoNS mastitis is more common in first-lactation cows than in older animals, and the infections can persist long enough to cause cumulative udder tissue damage.²⁰

The epidemiology varies by species. Some CoNS species appear to spread from the barn environment into the udder, while others seem to pass from cow to cow. For S. epidermidis and S. chromogenes, the limited genetic diversity among milk isolates suggests that a few well-adapted strains circulate within herds. For S. haemolyticus, the picture is messier, with many genotypes in both the environment and in milk.⁴

CoNS in Food Production

Not every role CoNS play is pathogenic. Several species are used deliberately in traditional fermented and cured meat products. In the production of pastırma, a Turkish dry-cured meat, researchers tested S. xylosus, S. equorum, and S. vitulinus as starter cultures and found they adapted well to the curing conditions and contributed positively to the product’s quality characteristics.²¹ CoNS starter cultures contribute to flavor development in cured meats by breaking down fats and proteins and by reducing nitrate to nitrite, which helps with color stability and preservation. These same species are commonly found in European-style fermented sausages as well, where they have been part of traditional production for centuries, often without anyone formally identifying them until modern sequencing came along.

How Labs Tell CoNS Species Apart

For years, clinical microbiology labs identified CoNS using biochemical test panels, which were slow and often inaccurate. Species-level identification was sometimes skipped entirely because CoNS were considered clinically irrelevant. That has changed with the recognition that different species carry different risk profiles.

The current gold standard for rapid identification is MALDI-TOF mass spectrometry, a technique that creates a protein fingerprint of the bacterium and matches it to a reference database. One study comparing MALDI-TOF to gene sequencing found 100% agreement between the two methods for clinically important CoNS.²² A broader comparison of five different identification methods confirmed MALDI-TOF as the best option for speed and accuracy, correctly identifying over 99% of 142 tested strains.²³ The practical upside is that a clinical lab can now determine the species of a CoNS isolate within minutes rather than days, which helps clinicians decide whether an isolate is likely a true pathogen or a contaminant.

Why Anti-Virulence Strategies Might Work Better Against CoNS Than Against S. aureus

One of the more intriguing findings in recent CoNS research is that the virulence architecture of these organisms may actually be easier to disrupt therapeutically than that of S. aureus. In S. aureus, the Agr quorum-sensing system controls a sprawling network of virulence factors, so knocking out one target still leaves many others active. In CoNS like S. haemolyticus, Agr control is more narrowly focused on PSM toxins, and the cytolytic capacity of those toxins is the dominant factor driving sepsis mortality in experimental models.¹⁵ A drug that blocks PSM production or Agr signaling in CoNS could therefore have a disproportionately large effect on disease severity. This represents a genuinely different therapeutic opportunity compared to S. aureus, where the same approach has been explored but is considered less likely to succeed because the virulence system is more redundant.

Development is still early, and no anti-virulence drug targeting CoNS has reached clinical use. But the finding that a single control node drives so much of the pathology in at least some CoNS species has shifted how researchers think about treating these infections beyond simply finding the next antibiotic.